Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $130K | Sell |
18,878
-2,983
| -14% | -$20.6K | ﹤0.01% | 4914 |
|
2025
Q1 | $116K | Sell |
21,861
-12,271
| -36% | -$65.2K | ﹤0.01% | 5151 |
|
2024
Q4 | $403K | Buy |
34,132
+22,245
| +187% | +$262K | ﹤0.01% | 4270 |
|
2024
Q3 | $245K | Buy |
11,887
+1,595
| +15% | +$32.9K | ﹤0.01% | 5060 |
|
2024
Q2 | $466K | Sell |
10,292
-22,108
| -68% | -$1M | ﹤0.01% | 4591 |
|
2024
Q1 | $1.27M | Buy |
+32,400
| New | +$1.27M | ﹤0.01% | 2893 |
|
2022
Q3 | – | Sell |
-2,780
| Closed | -$21K | – | 5816 |
|
2022
Q2 | $21K | Buy |
2,780
+638
| +30% | +$4.82K | ﹤0.01% | 5095 |
|
2022
Q1 | $34K | Sell |
2,142
-510
| -19% | -$8.1K | ﹤0.01% | 5230 |
|
2021
Q4 | $49K | Buy |
2,652
+2,059
| +347% | +$38K | ﹤0.01% | 4882 |
|
2021
Q3 | $18K | Sell |
593
-343
| -37% | -$10.4K | ﹤0.01% | 5056 |
|
2021
Q2 | $51K | Sell |
936
-1,448
| -61% | -$78.9K | ﹤0.01% | 4939 |
|
2021
Q1 | $141K | Buy |
2,384
+620
| +35% | +$36.7K | ﹤0.01% | 4441 |
|
2020
Q4 | $66K | Sell |
1,764
-1,168
| -40% | -$43.7K | ﹤0.01% | 3713 |
|
2020
Q3 | $158K | Buy |
2,932
+998
| +52% | +$53.8K | ﹤0.01% | 3316 |
|
2020
Q2 | $487K | Buy |
1,934
+1,430
| +284% | +$360K | ﹤0.01% | 2552 |
|
2020
Q1 | $79K | Buy |
+504
| New | +$79K | ﹤0.01% | 3163 |
|
2017
Q1 | – | Sell |
-2,255
| Closed | -$572K | – | 2777 |
|
2016
Q4 | $572K | Buy |
2,255
+1,734
| +333% | +$440K | ﹤0.01% | 1665 |
|
2016
Q3 | $106K | Buy |
+521
| New | +$106K | ﹤0.01% | 2603 |
|